Published in J Biol Chem on November 10, 1981
Quantitative measurement of SC5b-9 and C5b-9(m) in infarcted areas of human myocardium. Clin Exp Immunol (1990) 1.20
Fc-mediated binding of IgG to vimentin-type intermediate filaments in vascular endothelial cells. Proc Natl Acad Sci U S A (1984) 1.14
Biological effects of short-term, high-concentration exposure to methyl isocyanate. VI. In vitro and in vivo complement activation studies. Environ Health Perspect (1987) 0.95
The mitochondrial protein C1qbp promotes cell proliferation, migration and resistance to cell death. Cell Cycle (2011) 0.90
Antibody-independent interaction between the first component of human complement, C1, and the outer membrane of Escherichia coli D31 m4. Biochem J (1985) 0.86
Complement component 1, q subcomponent binding protein is a marker for proliferation in breast cancer. Exp Biol Med (Maywood) (2015) 0.75
Lymphocyte in vitro cytotoxicity: mechanisms of immune and non-immune small lymphocyte mediated target L cell destruction. J Immunol (1968) 4.66
Platelet-activating factor. Evidence for 1-O-alkyl-2-acetyl-sn-glyceryl-3-phosphorylcholine as the active component (a new class of lipid chemical mediators). J Biol Chem (1979) 4.31
Molecular analysis of the membrane attack mechanism of complement. J Exp Med (1972) 3.35
The membrane attack mechanism of complement. Verification of a stable C5-9 complex in free solution. J Exp Med (1973) 2.44
Asymmetrical crossing barriers in angiosperms. Proc Biol Sci (2001) 2.37
The membrane attack mechanism of complement. Isolation and subunit composition of the C5b-9 complex. J Exp Med (1975) 2.32
Physicochemical and functional identity of rabbit platelet-activating factor (PAF) released in vivo during IgE anaphylaxis with PAF released in vitro from IgE sensitized basophils. J Immunol (1979) 2.31
Antibodies against the mitochondrial fraction of liver after toxic liver damage in rats. Clin Exp Immunol (1966) 2.24
Activation of human neutrophils with 1-O-hexadecyl/octadecyl-2-acetyl-sn-glycerol-3-phosphorylcholine (platelet activating factor). J Immunol (1981) 2.19
Vasoactive properties of acetyl glyceryl ether phosphorylcholine and analogues. Lab Invest (1982) 2.14
Platelet-activating factor: receptors and signal transduction. Biochem J (1993) 2.12
Purification of the sixth and seventh component of human complement without loss of hemolytic activity. J Immunol (1976) 2.02
Lymphocyte in vitro cytotoxicity: characterization of human lymphotoxin. Proc Natl Acad Sci U S A (1968) 1.95
Lymphocyte in vitro cytotoxicity: specific release of lymphotoxin-like materials from tuberculin-sensitive lymphoid cells. Nature (1969) 1.94
Factors influencing the immune response. I. Effects of the physical state of the antigen and of lymphoreticular cell proliferation on the response to intravenous injection of bovine serum albumin in rabbits. Clin Exp Immunol (1967) 1.85
Complement-dependent proinflammatory properties of the Alzheimer's disease beta-peptide. J Exp Med (1998) 1.84
The C5b-6 complex: formation, isolation, and inhibition of its activity by lipoprotein and the S-protein of human serum. J Immunol (1978) 1.81
Pathobiology of the intravenous infusion of acetyl glyceryl ether phosphorylcholine (AGEPC), a synthetic platelet-activating factor (PAF), in the rabbit. J Immunol (1980) 1.77
Intravascular aggregation and pulmonary sequestration of platelets during IgE-induced systemic anaphylaxis in the rabbit: abrogation of lethal anaphylactic shock by platelet depletion. J Immunol (1977) 1.76
Naturally occurring anti-tissue antibodies in rat sera. Clin Exp Immunol (1966) 1.75
Structural changes in human serum albumin induced by ingestion of acetylsalicylic acid. J Clin Invest (1969) 1.75
C1q: isolation from human serum in high yield by affinity chromatography and development of a highly sensitive hemolytic assay. J Immunol (1979) 1.63
Identification of platelet activating factor isolated from rabbit basophils as acetyl glyceryl ether phosphorylcholine. J Biol Chem (1980) 1.61
A survey of physicians' attitudes and practices related to exercise promotion. Prev Med (1992) 1.61
Consumption of classical complement components by heart subcellular membranes in vitro and in patients after acute myocardial infarction. J Clin Invest (1975) 1.59
Respiratory and circulatory alterations induced by acetyl glyceryl ether phosphorylcholine, a mediator of IgE anaphylaxis in the rabbit. Am Rev Respir Dis (1980) 1.54
In vitro acetylation of plasma proteins, enzymes and DNA by aspirin. Nature (1968) 1.51
Bone morphogenetic protein-9. An autocrine/paracrine cytokine in the liver. J Biol Chem (2000) 1.48
Factors influencing the immune response. 3. The blocking effect of Corynebacterium parvum upon the induction of acquired immunological unresponsiveness to bovine serum albumin in the adult rabbit. Clin Exp Immunol (1968) 1.46
Production of lymphotoxin and migration inhibitory factor by established human lymphocytic cell lines. J Immunol (1970) 1.43
Human platelet stimulation by acetyl glyceryl ether phosphorylcholine. J Clin Invest (1981) 1.42
Molecular reorganization of lipid bilayers by complement: a possible mechanism for membranolysis. Proc Natl Acad Sci U S A (1979) 1.41
Structural similarities between C6 and C7 of human complement. J Immunol (1979) 1.41
Complement and neutrophil activation in the pathogenesis of ischemic myocardial injury. Circulation (1988) 1.39
Acetyl glyceryl ether phosphorylcholine (AGEPC). A putative mediator of cardiac anaphylaxis in the guinea pig. Circ Res (1984) 1.36
The SC5b-7 complex: formation, isolation, properties, and subunit composition. J Immunol (1977) 1.35
The membrane attack mechanism of complement. Reversible interactions among the five native components in free solution. J Exp Med (1973) 1.35
Morphologic basis of increased vascular permeability induced by acetyl glyceryl ether phosphorylcholine. Lab Invest (1984) 1.34
Decision making by parents and healthcare professionals when considering continued care for pediatric patients with cancer. Oncol Nurs Forum (1997) 1.32
Antibody-independent activation of human C1 after interaction with heart subcellular membranes. J Immunol (1973) 1.29
The regulation of pyruvate dehydrogenase in the isolated perfused rat heart. J Biol Chem (1978) 1.28
Induction of leukocytic infiltrates in rabbit skin by acetyl glyceryl ether phosphorylcholine. Lab Invest (1982) 1.26
The C5b-6 complex: reaction with C7, C8, C9. J Immunol (1978) 1.25
Complement localization and mediation of ischemic injury in baboon myocardium. J Clin Invest (1980) 1.24
In vitro activation of complement by isolated human heart subcellular membranes. J Immunol (1979) 1.24
Physicochemical characterization of fluid phase (SC5b-9) and membrane derived (MC5b-9) attack complexes of human complement purified by immunoadsorbent affinity chromatography or selective detergent extraction. Mol Immunol (1981) 1.22
Studies of the effects of beta-adrenergic agonists on the regulation of pyruvate dehydrogenase in the perfused rat heart. J Biol Chem (1980) 1.22
Stimulation of hepatic glycogenolysis by acetylglyceryl ether phosphorylcholine. J Biol Chem (1984) 1.21
Acetylglyceryl ether phosphorylcholine. A potent activator of hepatic phosphoinositide metabolism and glycogenolysis. J Biol Chem (1983) 1.21
Contraction of guinea pig ileal smooth muscle by acetyl glyceryl ether phosphorylcholine. Am J Physiol (1981) 1.21
Neoantigens of the membrane attack complex of human complement. Proc Natl Acad Sci U S A (1975) 1.19
Human platelet-initiated formation and uptake of the C5-9 complex of human complement. J Clin Invest (1976) 1.19
Mode of action of human C9: adsorption of multiple C9 molecules to cell-bound C8. J Immunol (1974) 1.17
Platelet-activating factor. Hosp Pract (Off Ed) (1983) 1.16
Platelet-activating factor-mediated vasoconstriction and glycogenolysis in the perfused rat liver. J Biol Chem (1986) 1.16
Endothelin, a potent peptide agonist in the liver. J Biol Chem (1990) 1.14
Acetylation of human serum albumin by acetylsalicylic acid. Science (1968) 1.13
Expression of C5a-like biological activities by the fifth component of human complement (C5) upon limited digestion with noncomplement enzymes without release of polypeptide fragments. J Exp Med (1983) 1.13
End-of-life decision making by adolescents, parents, and healthcare providers in pediatric oncology: research to evidence-based practice guidelines. Cancer Nurs (2001) 1.12
Lymphocyte in vitro cytotoxicity: characterization of mouse lymphotoxin. Cell Immunol (1970) 1.12
Agonist-dependent failure of neutrophil function in diabetes correlates with extent of hyperglycemia. J Leukoc Biol (2001) 1.11
Expression of bone morphogenetic protein-7 mRNA in normal and ischemic adult rat kidney. Am J Physiol (1999) 1.11
Development of complement-fixing 19S, anti-heart mitochondria autoantibody, following myocardial infarction in dogs. Circ Res (1971) 1.10
Differential effects of platelet depletion on the physiologic alterations of IgE anaphylaxis and acetyl glyceryl ether phosphorylcholine infusion in the rabbit. Am Rev Respir Dis (1981) 1.10
The analysis of acyl-coenzyme A derivatives by reverse-phase high-performance liquid chromatography. Anal Biochem (1983) 1.10
The C5b-9 complex: subunit composition of the classical and alternative pathway-generated complex. J Immunol (1976) 1.09
The effect of fatty acids on the regulation of pyruvate dehydrogenase in perfused rat liver. Eur J Biochem (1978) 1.08
Physical and chemical properties of platelet-activating factor obtained from human neutrophils and monocytes and rabbit neutrophils and basophils. Biochim Biophys Acta (1980) 1.08
PAF, a putative mediator of oral inflammation. Crit Rev Oral Biol Med (2000) 1.08
Complement-independent activation of the fifth component (C5) of human complement: limited trypsin digestion resulting in the expression of biological activity. J Immunol (1982) 1.07
Failure to induce tolerance to rat tissue antigens. Immunology (1967) 1.07
Role of pyruvate transporter in the regulation of the pyruvate dehydrogenase multienzyme complex in perfused rat liver. Biochemistry (1982) 1.06
C1Q receptors on cultured human gingival fibroblasts: analysis of binding properties. J Immunol (1983) 1.05
Regulation of the pyruvate dehydrogenase multienzyme complex. Annu Rev Nutr (1993) 1.05
Factors influencing the immune response. II. Effects of the physical state of the antigen and of lymphoreticular cell proliferation on the response to intraperitoneal injection of bovine serum albumin in rabbits. Clin Exp Immunol (1967) 1.05
Acetyl glyceryl ether phosphorylcholine. Intravascular alterations following intravenous infusion into the baboon. Lab Invest (1981) 1.04
Expression of nitric-oxide synthase in rat Kupffer cells is regulated by cAMP. J Biol Chem (1998) 1.04
Studies on the regulation of pyruvate dehydrogenase in the isolated perfused rat heart. J Biol Chem (1979) 1.04
Regulation of pyruvate dehydrogenase by fatty acid in isolated rat liver mitochondria. J Biol Chem (1976) 1.04
Studies on the relationship between ketogenesis and pyruvate oxidation in isolated rat liver mitochondria. J Biol Chem (1978) 1.04
The effect of acetylglyceryl ether phosphorylcholine on glycogenolysis and phosphatidylinositol 4,5-bisphosphate metabolism in rat hepatocytes. J Biol Chem (1984) 1.04
Osteogenic protein-1 and insulin-like growth factor I synergistically stimulate rat osteoblastic cell differentiation and proliferation. Endocrinology (1997) 1.04
Studies on the activation and inactivation of the branched chain alpha-keto acid dehydrogenase in the perfused rat heart. J Biol Chem (1980) 1.03
Regulation of pyruvate dehydrogenase complex in ischemic rat heart. Am J Physiol (1984) 1.03
Evidence for the regulation of the branched chain alpha-keto acid dehydrogenase multienzyme complex by a phosphorylation/dephosphorylation mechanism. Biochemistry (1982) 1.02
A quantitative genetic analysis of nuclear-cytoplasmic male sterility in structured populations of Silene vulgaris. Genetics (2001) 1.02
Characterization of inflammatory mediator release from purified human lung mast cells. Am Rev Respir Dis (1986) 1.01
Stimulation of glycogenolysis by adenine nucleotides in the perfused rat liver. Biochem J (1986) 1.01
Observations on the critical micellar concentration of 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine and a series of its homologs and analogs. Chem Phys Lipids (1984) 1.00
Regulation of the branched chain alpha-keto acid and pyruvate dehydrogenases in the perfused rat heart. J Biol Chem (1982) 0.99
Cardiovascular and metabolic costs of forward, backward, and lateral motion. Med Sci Sports Exerc (1998) 0.99
Leukocyte complement: neoantigens of the membrane attack complex on the surface of human leukocytes prepared from defibrinated blood. J Immunol (1978) 0.99